Correction: Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013).
作者信息
An Hye Jin, Lee Bonggi, Kim Dae Hyun, Lee Eun Kyeong, Chung Ki Wung, Park Min Hi, Jeong Hyoung Oh, Kim Sung Min, Moon Kyoung Mi, Kim Ye Ra, Kim Seong Jin, Yun Hwi Young, Chun Pusoon, Yu Byung Pal, Moon Hyung Ryong, Chung Hae Young
出版信息
Oncotarget. 2017 Jul 4;8(27):45030. doi: 10.18632/oncotarget.18922.
Abstract
摘要
相似文献
1
Correction: Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013).更正：新型过氧化物酶体增殖物激活受体（PPAR）泛激动剂2-(4-(5,6-亚甲基二氧基苯并[d]噻唑-2-基)-2-甲基苯氧基)-2-甲基丙酸（MHY2013）的生理学特征
Oncotarget. 2017 Jul 4;8(27):45030. doi: 10.18632/oncotarget.18922.
2
Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013).新型过氧化物酶体增殖物激活受体（PPAR）泛激动剂2-(4-(5,6-亚甲基二氧基苯并[d]噻唑-2-基)-2-甲基苯氧基)-2-甲基丙酸（MHY2013）的生理学特性
Oncotarget. 2017 Mar 7;8(10):16912-16924. doi: 10.18632/oncotarget.14818.
3
A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation.一种过氧化物酶体增殖物激活受体（PPAR）泛激动剂MHY2013通过促进脂肪酸氧化和抑制炎症来减轻与年龄相关的肝脏脂质积累。
Biol Pharm Bull. 2018;41(1):29-35. doi: 10.1248/bpb.b17-00371.
4
Synthesis, biological evaluation and molecular modeling of GW 501516 analogues.GW 501516 类似物的合成、生物评价和分子建模。
Arch Pharm (Weinheim). 2010 Nov;343(11-12):612-24. doi: 10.1002/ardp.201000189.
5
Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908).2-[4-(5-氯苯并[d]噻唑-2-基)苯氧基]-2-甲基丙酸（MHY908）对黑色素生成的抑制作用
Arch Pharm Res. 2015 Apr;38(4):505-11. doi: 10.1007/s12272-014-0532-0. Epub 2014 Dec 14.
6
Synthesis and dual PPARalpha/delta agonist effects of 1,4-disubstituted 1,2,3-triazole analogues of GW 501516.1,4-二取代 1,2,3-三唑类似物的合成及对 PPARalpha/delta 的双重激动作用 GW501516。
Eur J Med Chem. 2010 Jul;45(7):3047-55. doi: 10.1016/j.ejmech.2010.03.035. Epub 2010 Mar 27.
7
An insight into the photophysical properties of amide hydrogen bonded N-(benzo[d]thiazol-2-yl) acetamide crystals.
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Feb 15;173:572-577. doi: 10.1016/j.saa.2016.10.007. Epub 2016 Oct 14.
8
An efficient synthesis of a potent PPARpan agonist.一种强效PPAR泛激动剂的高效合成。
J Org Chem. 2006 Oct 13;71(21):8302-5. doi: 10.1021/jo061295n.
9
Synthesis of some new 5-(2-substituted-1,3-thiazol-5-yl)-2-hydroxy benzamides and their 2-alkoxy derivatives as possible antifungal agents.一些新型5-(2-取代-1,3-噻唑-5-基)-2-羟基苯甲酰胺及其2-烷氧基衍生物作为潜在抗真菌剂的合成
Eur J Med Chem. 2004 Oct;39(10):867-72. doi: 10.1016/j.ejmech.2004.06.003.
10
Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging.新型过氧化物酶体增殖物激活受体α（PPARα）激动剂MHY553通过在衰老过程中增加脂肪酸氧化和减轻炎症来缓解肝脂肪变性。
Oncotarget. 2017 Jul 11;8(28):46273-46285. doi: 10.18632/oncotarget.17695.
引用本文的文献
1
Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review.非酒精性脂肪性肝病的新兴治疗选择：一项系统综述。
World J Hepatol. 2023 Aug 27;15(8):1001-1012. doi: 10.4254/wjh.v15.i8.1001.
2
PPAR Pan Agonist MHY2013 Alleviates Renal Fibrosis in a Mouse Model by Reducing Fibroblast Activation and Epithelial Inflammation.PPAR 全激动剂 MHY2013 通过减少成纤维细胞激活和上皮炎症缓解小鼠模型的肾纤维化。
Int J Mol Sci. 2023 Mar 2;24(5):4882. doi: 10.3390/ijms24054882.
Zotero 插件